Viewing Study NCT02357992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:30 PM
Ignite Modification Date: 2026-02-24 @ 12:14 AM
Study NCT ID: NCT02357992
Status: COMPLETED
Last Update Posted: 2022-10-14
First Post: 2015-02-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung cancer View
None Non-small cell lung cancer View
None NSCLC View
None Squamous cell carcinoma View
None Adenocarcinoma with or without BAC features View
None Large cell carcinoma with or without neuroendocrine features View
None Neuroendocrine carcinoma View
None Bronchioloalveolar cell carcinoma View
None Stereotactic radiotherapy (SRT) View
None SRT View
None Stereotactic ablative radiotherapy View
None SABR View
None Radiation therapy View
None XRT View